QT interval prolongation in patients receiving bedaquiline-based regimens for drug-resistant tuberculosis in Sub-Saharan Africa: A systematic review and meta-analysis

Background: Drug-resistant tuberculosis (DR-TB) is a major public health challenge in Sub-Saharan Africa (SSA), worsened by high HIV prevalence and limited healthcare infrastructure. Bedaquiline, a cornerstone DR-TB treatment, is linked to QT interval prolongation, a risk factor for life-threatening...

Descripción completa

Detalles Bibliográficos

Autores principales:	Morrish Obol Okello, Ivaan Pitua, James Nelson Okema, Doris Ekwem, Felix Bongomin, Ronald Olum
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2026-05-01
Colección:	Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Materias:	Bedaquiline QT prolongation Drug-resistant tuberculosis Sub-Saharan Africa Meta-analysis
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S2405579426000148
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!